Articles

Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is one of the complications of Epstein-Barr virus (EBV) infection. Although the patients who have developed HLH following EBV have normal immune system, there are a few patients with EBV-induced immune deficiency who develop HLH as well. Here, we describe the case of a 10-year-old girl with neurological complications caused by EBV-induced HLH. The patient received rituximab, leading to weakening inflammation associated with EBV infection and suppression of disease through quick treatment.

Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2 002; 44:203–215

Henter JI, Horne AC, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.PediatrBloodCancer.2007; 48:124–131

Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.CritRevOncolHematol.2002; 44:259–272 2.

Henter JI. Hemophagocytic lymphohistiocytosis (HLH): symptoms, signs and diagnosis of a rapidly fatal childhood disease.2004. Available at: www.histio.org/site/apps/nl/content2. asp?c_kiKTL4PQLvF&b_1850031&ct_2592057. AccessedJanuary 25, 2007

Manual of Pediatric Hematology and Oncology. DOI: 10.1016/B978-0-12-375154-6.00001-XCopyright r 2011 Elsevier Inc. All rights reserved.

Sumegi J, Johnson J, Filipovich AH, Zhang K. Lymphoproliferative disease, X-linked. 2004. Available at: www.genetests org/query?gene_SH2D1A. Accessed January 25, 2007

Coffey AJ, Brooksbank RA, Brandau O, et al. Host response toEBV infection in X-linked lymphoproliferative disease resultsfrom mutations in an SH2-domain encoding gene. Nat Genet.1998; 20:129–

Imashuku S, Hlbi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr. 1997; 130:352–357

Imashuku S, Hibi S, Ohara T, et al. Effective controlof Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood. 1999; 93:1869–1874.

Lee JS, Kang JH, Lee GK, Park HJ. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol. J Korean Med Sci. 2005; 20:209–214.

Imashuku S, Tabata Y, Teramura T, Hibi S. Treatment strategies for Epstein-Barr virus- associated hemophagocytic lymphohistiocytosis (EBV-HLH). Leuk Lymphoma. 2000 Sep; 39(1-2):37-49.

Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 2004; 3:69–75

Lay JD, Chuang SE, Rowe M, Su IJ. Epstein-Barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome. J Biomed Sci. 2003; 10: 146–155.

Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997; 100:1969–1979.

Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis(EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol. 2003; 41:103–109.

Milone MC, Tsai DE, Hodinka RL, et al. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood. 2005; 105:994–996.

Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer. 2009 Aug; 53(2):184-90. doi: 10.1002/pbc.22037.

Files
IssueVol 7, No 1 (2013) QRcode
SectionArticles
Keywords
Epstein - Barr virus Etanercept Hemophagocytic lymphohistiocytosis Infectious mononucleosis Systemic inflammatory response syndrome X-Linked lymphoproliferative disease
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Goudarzipour K, Kajiyazdi M, Mahdaviyani A. Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis. Int J Hematol Oncol Stem Cell Res. 1;7(1):39-42.